GWSA
HELP

Global Wealth Strategies & Associates’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Global Wealth Strategies & Associates’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-526
Closed -$4.3K – 559
2025
Q4 		$4.3K Hold
526
– – ﹤0.01% 376
2025
Q3 		$3.1K Hold
526
– – ﹤0.01% 367
2025
Q2 		$4.41K Hold
526
– – ﹤0.01% 269
2025
Q1 		$3.33K Hold
526
– – ﹤0.01% 353
2024
Q4 		$4.64K Hold
526
– – ﹤0.01% 271
2024
Q3 		$4.68K Buy
+526
New +$5.2K ﹤0.01% 246

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Global Wealth Strategies & Associates's HELP Position: Q1 2026 in Review

Global Wealth Strategies & Associates sold out of Helus Pharma Inc. Common Stock (HELP) in Q1 2026, closing a stake of 526 shares — an estimated $4.3K sold.

Global Wealth Strategies & Associates first reported a position in HELP in Q3 2024 and held it in 6 quarters. The position peaked at $4.68K in Q3 2024. 81 funds tracked by Wall St. Rank hold HELP as of Q1 2026.

  • Global Wealth Strategies & Associates reported no remaining Helus Pharma Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • Global Wealth Strategies & Associates sold 526 Helus Pharma Inc. Common Stock shares in Q1 2026, an estimated $4.3K.
  • Global Wealth Strategies & Associates first reported a position in Helus Pharma Inc. Common Stock in Q3 2024 and held it in 6 quarters.
  • Global Wealth Strategies & Associates's Helus Pharma Inc. Common Stock position peaked at $4.68K in Q3 2024.
  • 81 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q1 2026.

Based on Global Wealth Strategies & Associates's 13F filing for Q1 2026, filed 3 Apr 2026.